UPDATE 1-Former Shkreli-led drug developer pledges responsible pricing

April 11 (Reuters) - A biotechnology company, previously led

by controversial former drug executive Martin Shkreli, on Monday

vowed not to engage in aggressive pricing and to develop a

transparent...

Read more